Columbia University DSI Alumni Use Machine Learning to Discover Coronavirus Treatments

Two graduates of the Data Science Institute (DSI) at Columbia University are using computational design to quickly discover treatments for the coronavirus. Andrew Satz and Brett Averso are chief executive officer and chief technology officer, respectively, of EVQLV, a startup creating algorithms capable of computationally generating, screening, and optimizing hundreds of millions of therapeutic antibodies. They apply their technology to discover treatments most likely to help those infected by the virus responsible for COVID-19.